iaslc Home
Home
Featured Topics
Diagnostic Oncology
Early Detection & Screening
Evolving Standards of Care
Global Initiatives
Meeting News
Names & News
Nursing & Allied Health
Patient Advocacy
Radiation Oncology
Regulatory News
Risk Assessment and Reduction
Society News
Supportive & Palliative Care
Surgical Oncology
Tobacco & Smoking Cessation
WCLC News
WCLC News
About Us
Menu
Home
Featured Topics
Diagnostic Oncology
Early Detection & Screening
Evolving Standards of Care
Global Initiatives
Meeting News
Names & News
Nursing & Allied Health
Patient Advocacy
Radiation Oncology
Regulatory News
Risk Assessment and Reduction
Society News
Supportive & Palliative Care
Surgical Oncology
Tobacco & Smoking Cessation
WCLC News
WCLC News
About Us
Home
View Featured Industry Events
This event has passed.
IS16: Actionable Biomarkers in Early-Stage NSCLC
September 9 @ 12:30
-
13:30
PDT
«
IS13: Accelerating Treatment Initiation with Next-Day NGS: Insights from a Multidisciplinary Collaboration Program in Precision Oncology
IS17: Lung Cancer Tumor Board
®
: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
»
+ Add to iCalendar
+ Add to Google Calendar
Details
Date:
September 9
Time:
12:30 - 13:30
PDT
Event Category:
Industry Symposium
SEARCH ILCN
Archives
Archives
Select Month
November 2024
October 2024
September 2024
August 2024
July 2024
June 2024
May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
June 2020
May 2020
April 2020
March 2020
February 2020
December 2019
November 2019
August 2019
May 2019
April 2019
February 2019
December 2018
November 2018
August 2018
June 2018
May 2018
April 2018
February 2018
December 2017
September 2017
August 2017
June 2017
May 2017
April 2017
February 2017
January 2017
November 2016
September 2016
June 2016
April 2016
Popular Articles
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Patterns of Failure after PACIFIC: How to Address Disease Recurrence after Chemoradiotherapy and Immunotherapy
FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
MARS2: Decortication Plus Chemotherapy Associated with Worse Outcomes for Resectable Mesothelioma
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
HARMONi-2 Study Findings May Reshape the Therapeutic Paradigm of Frontline Driver Mutation-Negative Advanced NSCLC
Analysis of Membrane-Bound TROP2 in TROPION-Lung01 Underscores Seminal Advance in Lung Cancer Digital Pathology